Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

SZSE:300534.SZ

9.22 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Revenue 1,080.05413.247287.813254.9239.003203.166269.587269.681277.361301.575274.89212.676133.366
Cost of Revenue 386.229249.524195.421171.8148.539116.765181.463171.915169.408200.778202.367161.604101.626
Gross Profit 693.821163.72392.39283.190.46486.40188.12497.766107.953100.79772.52351.07331.74
Gross Profit Ratio 0.6420.3960.3210.3260.3790.4250.3270.3630.3890.3340.2640.240.238
Reseach & Development Expenses 30.1739.3746.6975.9747.4126.7326.1366.35610.199.8098.1100
General & Administrative Expenses 16.6078.8284.7262.8422.8183.4573.7742.2962.1931.4363.43112.3610.567
Selling & Marketing Expenses 508.02691.70367.18852.68845.6147.26346.56725.75312.88315.49910.8928.9576.515
SG&A 524.633100.53171.91555.5348.42850.7250.3428.04915.07616.93514.32321.31717.082
Other Expenses 1.825.4674.6341.5730.501-0.0080.0364.6212.1453.0762.5371.8352.875
Operating Expenses 592.503133.8397.53978.24267.15171.46669.47347.84335.14234.96729.73922.5317.976
Operating Income 95.226.733-9.3832.24519.53313.52418.07950.11269.81868.00345.69627.89813.557
Operating Income Ratio 0.0880.065-0.0330.0090.0820.0670.0670.1860.2520.2250.1660.1310.102
Total Other Income Expenses Net -4.2995.4674.6341.5730.501-0.0080.0364.6212.1453.0762.4761.8352.875
Income Before Tax 97.0232.2-4.7483.81820.03313.51518.11554.73371.96371.07848.17329.73316.432
Income Before Tax Ratio 0.090.078-0.0160.0150.0840.0670.0670.2030.2590.2360.1750.140.123
Income Tax Expense 13.1681.9041.550.5364.6691.2381.0037.48111.28610.6547.2614.6512.624
Net Income 61.64825.826-9.1061.83112.77812.27817.11247.25260.67760.42440.91225.25613.897
Net Income Ratio 0.0570.062-0.0320.0070.0530.060.0630.1750.2190.20.1490.1190.104
EPS 0.20.085-0.030.0060.0420.0410.0560.190.270.270.190.20.17
EPS Diluted 0.20.085-0.030.0060.0420.0410.0560.190.270.270.190.20.17
EBITDA 140.09858.56724.28427.93344.64134.2636.42364.48979.61874.36451.69929.51813.186
EBITDA Ratio 0.130.1420.0840.110.1870.1690.1350.2390.2870.2470.1880.1390.099